Breast cancer drug could help prolong survival for children with brain tumors, study finds
Fox News
A drug called ribociclib, currently used to treat breast cancer, could prove to be an effective weapon against pediatric high-grade glioma, an aggressive childhood brain cancer, a new study says.
"We are finally starting to see more targeted therapies come out for different forms of brain cancer." "This research helps us have a better understanding of what is driving this devastating disease in children." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
In the study, which was published in the journal Cancer Cell, a 10-year-old patient who had experienced a second relapse of pediatric high-grade glioma — and had no other treatment options — experienced 17 months of "progression-free survival" after taking ribociclib.